US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
- 0.038
- +0.000+0.27%
15min DelayTrading Apr 25 14:23 ET
3.76MMarket Cap-470P/E (TTM)
0.044High0.038Low15.01KVolume0.038Open0.038Pre Close630.66Turnover0.02%Turnover RatioLossP/E (Static)100.08MShares0.27252wk High-1.14P/B2.55MFloat Cap0.02152wk Low--Dividend TTM67.83MShs Float365.000Historical High--Div YieldTTM17.33%Amplitude0.021Historical Low0.042Avg Price1Lot Size
About Navidea Biopharmaceuticals Company
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
Company Profile
SymbolNAVB
Company NameNavidea Biopharmaceuticals
Listing DateFeb 10, 2011
Issue Price6.00
Founded1983
CEODr. Michael S. Rosol, PhD
MarketPink Market
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4995 Bradenton Avenue,Suite 240
CityDublin
ProvinceOhio
CountryUnited States of America
Zip Code43017-3552
Phone1-614-793-7500
Websitehttp://www.navidea.com
Company Executives
- Name
- Position
- Salary
- Craig Dais
- Chief Financial Officer and Principal Accounting Officer
- --
- John K. Scott, Jr
- Vice Chairman of the Board
- 110.15K
- Joshua M. Wilson
- Director
- 17.72K
- Dana J. Moss, J.D.
- Director
- --
- Dr. Jill Bieker Stefanelli, PhD
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg